Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan D. Frazier currently holds 4,894,035 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan D. Frazier has been a net neutral trader of CADX stock. They have purchased $0 and sold $0 worth of shares.
Alan D. Frazier's most recent insider trade was on Mar 19, 2014, when they sold 4,796,711 shares at $14.00 per share.
Alan D. Frazier serves as Executive at CADENCE PHARMACEUTICALS INC (CADX). They have executed 17 insider transactions totaling $0 over their tenure at the company.
Alan D. Frazier holds the position of Executive at CADENCE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Alan D. Frazier has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Alan D. Frazier was on Mar 19, 2014, when they sold $67.2M worth of CADX shares. This transaction involved 4,796,711 shares at $14.00 per share.
Alan D. Frazier currently owns 4,894,035 shares of CADENCE PHARMACEUTICALS INC (CADX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan D. Frazier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan D. Frazier has 17 Form 4 filings on record as an insider at CADENCE PHARMACEUTICALS INC.
Set alerts for Alan D. Frazier and 40,000+ other insiders.